By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

AVEO Oncology (Formerly known as AVEO Pharmaceuticals, Inc.) 

75 Sidney Street, 4th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-299-5000 Fax: 617-995-4995


SEARCH JOBS


Key Statistics


Email: info@aveopharma.com
Ownership: Public

Web Site: AVEO Oncology
Employees:
Symbol: AVEO
 





Collaborations

Merck & Co.  Cancer





Company News
AVEO Oncology (AVEO) Relocates HQ to Smaller Facility in Cambridge After Corporate Restructuring 5/26/2015 5:19:14 AM
AVEO Oncology (AVEO) Announces Presentation Of Final Results Of Extension Study 902 And FDA Regulatory Feedback For Advancing Tivozanib In Renal Cell Carcinoma 5/20/2015 12:29:20 PM
AVEO Oncology (AVEO) Announces Presentation Of Final Results Of Extension Study 902 And FDA Regulatory Feedback For Advancing Tivozanib In Renal Cell Carcinoma 5/20/2015 8:10:47 AM
AVEO Oncology (AVEO) Reports First Quarter 2015 Financial Results 5/7/2015 12:49:10 PM
AVEO Oncology (AVEO) Names Keith S. Ehrlich As Chief Financial Officer 4/22/2015 11:01:58 AM
AVEO Oncology (AVEO) Announces Presentation Of AV-380 Preclinical Data In Cancer Associated Cachexia At 2015 Annual Meeting Of The AACR 4/20/2015 11:20:58 AM
AVEO Oncology (AVEO) Announces Presentation Of Phase 2 Study Analysis Showing Longer PFS With Tivozanib Compared To Bevacizumab In Low Serum NRP-1 Patients With Advanced CRC 3/6/2015 10:42:02 AM
AVEO Oncology (AVEO) Reports Full Year 2014 Financial Results 3/6/2015 7:49:53 AM
AVEO Oncology (AVEO) To Host Conference Call To Discuss Presentation Of Final Results And Biomarker Analysis From Phase 2 Study Of Tivozanib In Patients With Advanced Colorectal Cancer 2/27/2015 10:53:27 AM
AVEO Oncology (AVEO) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/12/2015 10:25:03 AM
12345678910...
//-->